Skip to main content
. Author manuscript; available in PMC: 2015 Feb 10.
Published in final edited form as: Gene. 2013 Dec 3;535(2):218–224. doi: 10.1016/j.gene.2013.11.031

Fig. 3.

Fig. 3

Increased expression of mdig predicates poorer overall survival (OS, A), distant metastasis free survival (DMFS, B), relapse free survival (RFS, C), and post-progression survival (PPS, D) of the breast cancer patients.